EMvision Medical Devices Limited is a healthcare technology company specializing in the development and commercialization of advanced neurodiagnostic medical devices. Its primary focus is on portable, non-invasive brain scanners designed for rapid and accurate stroke diagnosis and monitoring. EMvision’s flagship products include both bedside imaging devices and ultra-lightweight scanners intended for pre-hospital use by first responders, addressing urgent medical imaging needs in settings where traditional methods are impractical. By facilitating earlier stroke detection, the company's devices can significantly impact patient outcomes, making them particularly valuable in emergency and acute care environments. Founded in 2017 and based in Macquarie Park, Australia, EMvision plays an important role in the medical device sector by contributing innovative solutions that integrate cutting-edge research developed in collaboration with leading institutions such as The University of Queensland. Within the financial market, EMvision Medical Devices Limited represents a defensive healthcare asset, reflecting its commitment to essential medical technologies that support critical care infrastructure and improve clinical efficiency.